GS0401: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells
DM0000: The mark consists of the terms "COMPREHENSIVE CELL SOLUTIONS" in white text with gray shadowing, positioned to the right of a stylized letter "C". The stylized letter "C" is divided into four segments, changing from light blue to dark blue from top to bottom. Solid bubbles surround the "C" also in the same light blue and dark blue radiating from each segment.
GS0391: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, storage of blood and stem cells
CC0000: The color(s) light blue, dark blue, white and gray is/are claimed as a feature of the mark.
GS0351: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes
GS0441: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow
DS0000: "COMPREHENSIVE CELL SOLUTIONS"
GS0421: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory, pharmaceutical research services and pharmaceutical clinical trials for others
Case File Event Statements
12/13/2017 - 7 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
12/17/2017 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
12/19/2017 - 7 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
3/13/2018 - 7 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
3/20/2018 - 7 years ago
5 - PRIORITY ACTION WRITTENType:CPRA
3/20/2018 - 7 years ago
7 - NOTIFICATION OF PRIORITY ACTION E-MAILEDType:GPRN
3/20/2018 - 7 years ago
6 - PRIORITY ACTION E-MAILEDType:GPRA
5/29/2018 - 6 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
5/29/2018 - 6 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
5/29/2018 - 6 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
6/4/2018 - 6 years ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
6/27/2018 - 6 years ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
7/17/2018 - 6 years ago
13 - PUBLISHED FOR OPPOSITIONType:PUBO
10/2/2018 - 6 years ago
15 - REGISTERED-PRINCIPAL REGISTERType:R.PR
10/2/2023 - a year ago
16 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1
12/6/2024 - 4 months ago
19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVEDType:REAP